Stent Restenosis Clinical Trials

10 recruitingLast updated: May 13, 2026

There are 10 actively recruiting stent restenosis clinical trials across 9 countries. Studies span Not Applicable, Phase 1, Phase 2, Phase 4. Top locations include Badalona, Catalonia, Spain, Beijing, Beijing Municipality, China, Biella, Biella, Italy. Updated daily from ClinicalTrials.gov.


Stent Restenosis Trials at a Glance

10 actively recruiting trials for stent restenosis are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Badalona, Beijing, and Biella. Lead sponsors running stent restenosis studies include Fu Wai Hospital, Beijing, China, Luzerner Kantonsspital, and Concept Medical Inc..

Browse stent restenosis trials by phase

Treatments under study

About Stent Restenosis Clinical Trials

Looking for clinical trials for Stent Restenosis? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Stent Restenosis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Stent Restenosis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting
Not Applicable

Optimal Strategy to Correct Stent underexpAnsion in Resistant Lesions

Coronary angioplastyCoronary Artery DiseaseCoronary Artery Disease (CAD)+10 more
University Hospital, Clermont-Ferrand80 enrolled2 locationsNCT07316504
Recruiting

Intravascular Imaging-Guided Versus Angiography- Guided PCI in Patients With DES-ISR

In-stent RestenosisPCIIntravascular Imaging Device
Nanjing First Hospital, Nanjing Medical University1,500 enrolled1 locationNCT07297641
Recruiting
Phase 4

Anti-inflammatory Therapy for Recurrent In-stent Restenosis

In-stent Restenosis
Fu Wai Hospital, Beijing, China252 enrolled4 locationsNCT06090890
Recruiting
Phase 1Phase 2

Pilot Study of the α Prototype NIMBLE System: Feasibility, Safety, and Initial Performance in Non-Invasive Detection of Coronary In-Stent Restenosis

In-stent RestenosisStent FractureStent Complication
Nimble Diagnostics S.L.30 enrolled1 locationNCT06968858
Recruiting
Not Applicable

MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

Cardiovascular DiseasesCoronary Artery DiseaseIn-stent Restenosis
Concept Medical Inc.492 enrolled28 locationsNCT05908331
Recruiting
Not Applicable

Intracoronary Optical Coherence Tomography Guidance Vs. Angiography Only Guidance for Treatment of Coronary In-stent Restenosis

Coronary Artery DiseaseStentStent Restenosis
San Luigi Gonzaga Hospital360 enrolled12 locationsNCT06779110
Recruiting
Not Applicable

Optimal Treatment for Coronary Drug Eluting Stent In-stent Restenosis

Coronary Stent Restenosis
Semmelweis University Heart and Vascular Center150 enrolled2 locationsNCT04862052
Recruiting
Not Applicable

The Value of IVL Compared To OPN Non-Compliant Balloons for Treatment of RefractorY Coronary Lesions (VICTORY) Trial

Coronary DiseaseCoronary Artery DiseaseCoronary Artery Calcification+2 more
Luzerner Kantonsspital280 enrolled1 locationNCT05346068
Recruiting

Safety and Efficacy of Paclitaxel Coated PTCA Balloon Catheter With a Shellac Plus Vitamin E Excipient (GENOSS® DCB) in Patients With Coronary In-stent Restenosis (ISR): A Prospective, Multi-center, Observational Study

Coronary Artery DiseaseIn-stent Restenosis
Seoul National University Hospital1,000 enrolled1 locationNCT06104007
Recruiting
Not Applicable

Copenhagen Mesenteric Stent Study - A Randomized Trial of Stent Versus Covered Stent Treatment for Chronic Mesenteric Ischemia

Stent ThrombosisStent RestenosisMesenteric Ischemia+7 more
Rigshospitalet, Denmark98 enrolled1 locationNCT05244629